Infectious Diseases in Clinical Practice最新文献_第7页

Infectious and Noninfectious Complications After Gluteal Augmentation Surgery 臀隆手术后的感染性和非感染性并发症

IF 0.5

Infectious Diseases in Clinical Practice Pub Date : 2023-07-01 DOI: 10.1097/ipc.0000000000001281

Richard D. Kang, Heeya Shah, John N. Greene

引用次数: 0

Comparison of Short-Term Infectious Rates Related to Implantable Venous Port Placement With and Without Prophylactic Antibiotic Administration 预防性使用抗生素与不使用预防性使用抗生素的植入式静脉置入术短期感染率的比较

IF 0.5

Infectious Diseases in Clinical Practice Pub Date : 2023-07-01 DOI: 10.1097/ipc.0000000000001267

R. Frimpong, E. Takahashi, Minn Thant

{"title":"Comparison of Short-Term Infectious Rates Related to Implantable Venous Port Placement With and Without Prophylactic Antibiotic Administration","authors":"R. Frimpong, E. Takahashi, Minn Thant","doi":"10.1097/ipc.0000000000001267","DOIUrl":"https://doi.org/10.1097/ipc.0000000000001267","url":null,"abstract":"\u0000 The purpose of this study is to determine the rate of short-term central line-associated bloodstream infections (CLABSI) related to port placement in patients who received prophylactic intravenous antibiotics compared with those who did not receive prophylactic antibiotics. A retrospective review of 545 consecutive patients who underwent implantable port placement at Mayo Clinic, Rochester, Minnesota, from May 2020 to June 2021 was conducted. A total of 270 patients underwent port placement with prophylactic antibiotics administration. A total of 275 patients underwent port placement without the administration of antibiotics. The rate of short-term or 30-day CLABSI in both groups was reviewed. Indications for port placement included vascular access for chemotherapy and need for long-term vascular access for intravenous hydration, intravenous immunoglobulin infusion, electroconvulsive therapy, and photophoresis. Short-term infections occurred in a total of 3 of 545 patients (0.55%). Rate of short-term infection in patients who had port placement without prophylactic antibiotics was 2 of 275 (0.72%). Rate of short-term infection in patients who underwent port placement with prophylactic antibiotics was 1 of 270 (0.37). All 3 patients presented with bacteremia and were treated with port explantation and intravenous antibiotics. Overall, 30-day CLABSI in 545 patients who underwent port placement was 0.55%. There was no significant difference in the rate of short-term infections in the group who received prophylactic antibiotics (0.37%) compared with patients who did not receive any preprocedural antibiotics (0.72%).","PeriodicalId":13952,"journal":{"name":"Infectious Diseases in Clinical Practice","volume":" ","pages":""},"PeriodicalIF":0.5,"publicationDate":"2023-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"47208801","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 1

Clearance of Persistent Methicillin-Susceptible Staphylococcus lugdunensis Bacteremia Using Nafcillin Plus Ertapenem Combination Therapy Nafcillin加Ertapenem联合治疗持久性甲氧西林敏感卢顿葡萄球菌菌血症

IF 0.5

Infectious Diseases in Clinical Practice Pub Date : 2023-07-01 DOI: 10.1097/ipc.0000000000001277

I. Sharma, J. Hodges, S. Moonah, D. Shirley

{"title":"Clearance of Persistent Methicillin-Susceptible Staphylococcus lugdunensis Bacteremia Using Nafcillin Plus Ertapenem Combination Therapy","authors":"I. Sharma, J. Hodges, S. Moonah, D. Shirley","doi":"10.1097/ipc.0000000000001277","DOIUrl":"https://doi.org/10.1097/ipc.0000000000001277","url":null,"abstract":"\u0000 \u0000 Staphylococcus lugdunensis is a coagulase-negative staphylococcus that can cause serious infection similar to Staphylococcus aureus. Limited therapeutic options are available for patients with staphylococcal bacteremia who fail to respond to standard monotherapy, particularly when source control of infection is not feasible, driving the need for improved synergistic antibiotic combinations to enhance medical management. We present the case of a 58-year-old patient with persistent S. lugdunensis bacteremia for over 1 week despite appropriate therapy with nafcillin. Blood cultures were successfully sterilized following the addition of ertapenem salvage therapy, with rapid blood culture clearance within 2 days of initiation. To our knowledge, this is the first report of using ertapenem in combination with an antistaphylococcal penicillin to specifically clear persistent S. lugdunensis bacteremia. Similar success has been reported using this combination to treat methicillin-susceptible S. aureus infections; hence, our report provides further support for the benefit of this combination for staphylococcal infections.","PeriodicalId":13952,"journal":{"name":"Infectious Diseases in Clinical Practice","volume":" ","pages":""},"PeriodicalIF":0.5,"publicationDate":"2023-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"45510558","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

A Case of Mycobacterium avium Complex Vertebral Osteomyelitis in a Patient With Human Immunodeficiency Virus 禽分枝杆菌复合椎体骨髓炎伴人类免疫缺陷病毒1例

IF 0.5

Infectious Diseases in Clinical Practice Pub Date : 2023-07-01 DOI: 10.1097/ipc.0000000000001283

Kirtan Amin, Yasmin Rosshandler, J. Norris, Folasade Arinze

{"title":"A Case of Mycobacterium avium Complex Vertebral Osteomyelitis in a Patient With Human Immunodeficiency Virus","authors":"Kirtan Amin, Yasmin Rosshandler, J. Norris, Folasade Arinze","doi":"10.1097/ipc.0000000000001283","DOIUrl":"https://doi.org/10.1097/ipc.0000000000001283","url":null,"abstract":"\u0000 \u0000 Mycobacterium avium complex (MAC) infection is one of the most common bacterial opportunistic infections in persons living with human immunodeficiency virus (PLWH). Mycobacterium avium complex infections are caused by either M. avium or Mycobacterium intracellulare, which are nontuberculous mycobacterial species. Mycobacterium avium complex is prevalent in soil, water, and animals in the environment. Mycobacterium avium complex infections are commonly seen in persons with CD4 counts less than 50 cells/μL and are the most common cause of disseminated disease in immunocompromised patients. Vertebral osteomyelitis caused by MAC, however, remains uncommon in PLWH, with few cases reported in the literature (Lancet Infect Dis. 2004;4:557–565; Infect Dis Clin Pract. 2001;10:17–20). We present a case of vertebral osteomyelitis secondary to MAC in a person with human immunodeficiency virus and compare 10 other cases reported in the literature. Our case also highlights the importance of resuming secondary MAC prophylaxis when CD4 counts decline below 100 cells/μL in PLWH.","PeriodicalId":13952,"journal":{"name":"Infectious Diseases in Clinical Practice","volume":" ","pages":""},"PeriodicalIF":0.5,"publicationDate":"2023-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"43704574","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Fulminant Myocarditis Associated With Parvovirus B19 and Epstein-Barr Virus Coinfection 与细小病毒B19和EB病毒共感染相关的暴发性心肌炎

IF 0.5

Infectious Diseases in Clinical Practice Pub Date : 2023-07-01 DOI: 10.1097/ipc.0000000000001280

C. L. Yan, G. Gupta, L. P. Guido, P. Ruiz, L. Grazette, E. Bauerlein, N. T. Rivera

{"title":"Fulminant Myocarditis Associated With Parvovirus B19 and Epstein-Barr Virus Coinfection","authors":"C. L. Yan, G. Gupta, L. P. Guido, P. Ruiz, L. Grazette, E. Bauerlein, N. T. Rivera","doi":"10.1097/ipc.0000000000001280","DOIUrl":"https://doi.org/10.1097/ipc.0000000000001280","url":null,"abstract":"\u0000 Parvovirus B19 (PVB19) and Epstein-Barr virus (EBV) commonly cause infection worldwide, with most persons infected during childhood. Their disease courses are usually mild and brief; however, PVB19 and EBV have been implicated as etiologies of viral myocarditis. We report a case of PVB19 and EBV coinfection associated with fulminant lymphocytic myocarditis. We address the implications of the case, including the differential diagnosis, immunomodulatory treatment considerations, and evidence for the pathologic roles of PVB19, EBV, and coinfection in myocarditis. Although the pathogenic roles of PVB19 or EBV alone in myocarditis are not well established, coinfection of PVB19 and EBV may unlock their pathogenic roles causing fulminant myocarditis. Treatment with steroids and intravenous immunoglobulin G in a patient with rapid clinical deterioration despite the presence of active infection on endomyocardial biopsy by polymerase chain reaction can result in a safe and quick recovery of fulminant viral myocarditis. Early and aggressive intervention, including both mechanical circulatory support and immunomodulatory therapy, may be key to improved outcomes in cases of fulminant myocarditis.","PeriodicalId":13952,"journal":{"name":"Infectious Diseases in Clinical Practice","volume":" ","pages":""},"PeriodicalIF":0.5,"publicationDate":"2023-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"48829973","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

A Young Man With Hemoptysis and a Cystic Lung Mass 一名年轻男子出现咯血和囊性肺部肿块

IF 0.5

Infectious Diseases in Clinical Practice Pub Date : 2023-06-27 DOI: 10.1097/ipc.0000000000001276

M. Collins, Tiffany Yu, Elizabeth Gancher, M. Altshuler, T. Grenda

引用次数: 0

The Use of Last-Line Antibiotics for the Treatment of COVID-19 Is a Risk to Disarm Humanity Against Future Antibiotic-Resistant Infectious Diseases 使用最后一线抗生素治疗COVID-19是人类抵御未来抗生素耐药性传染病的风险

IF 0.5

Infectious Diseases in Clinical Practice Pub Date : 2023-06-27 DOI: 10.1097/ipc.0000000000001272

Seyed Soheil Hosseininasab, M. Gorji, Seyyedeh Sanaz Hosseini, M. T. Moghadam

引用次数: 1

Cryptococcal Meningitis in an Immunocompetent Chronic Cannabis User Requiring Temporary Lumbar Drain Placement 需要临时腰椎引流管放置的免疫正常慢性大麻使用者的隐球菌性脑膜炎

IF 0.5

Infectious Diseases in Clinical Practice Pub Date : 2023-06-27 DOI: 10.1097/ipc.0000000000001268

Oyiyechukwu Onwudiwe, Harish Gopalakrishna, G. S. Crowther, Prashanth Santhekadur

引用次数: 0

Atypical Erythema Multiforme, a Clinical Mimicker of Monkeypox 非典型多型红斑——猴痘的临床模拟

IF 0.5

Infectious Diseases in Clinical Practice Pub Date : 2023-06-27 DOI: 10.1097/ipc.0000000000001263

A. Njoroge, Bennadette Maramara, Miguel Saldivar

引用次数: 0

Predictors of Positive Repeat Blood Cultures in Patients With Gram-Negative Bacilli Bacteremia 革兰氏阴性杆菌菌血症患者重复血培养阳性的预测因素

IF 0.5

Infectious Diseases in Clinical Practice Pub Date : 2023-06-20 DOI: 10.1097/ipc.0000000000001274

Daniel Gao, J. Ek, Emily George, Paige Ewing, Michael Oravec, J. Myers

引用次数: 0